+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones



Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones



Journal of Clinical Gastroenterology 4(2): 133-135



Monooctanoin, a cholesterol gallstone solvent, has been gaining wide acceptance as an effective safe agent for dissolving retained common bile duct stones when infused into the biliary tract. A woman with choledocholithiasis who received infusions of this agent into the biliary tract on three different occasions developed systemic side effects on each occasion. The severity of the side effects necessitated discontinuation of monooctanoin therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 044512211

Download citation: RISBibTeXText

PMID: 7086106

DOI: 10.1097/00004836-198204000-00007


Related references

Monooctanoin dissolution of gallstones via a cholecystostomy tube. Radiology 153(2): 547-547, 1984

In vitro dissolution of cholesterol gallstones with sodium cholate, heparin and monooctanoin. Revista Medica de Chile 109(7): 601-605, 1981

Evaluation of garlic oil as a contact dissolution agent for gallstones: comparison with monooctanoin. Tropical Gastroenterology 21(4): 177-179, 2001

A new technique for the rapid dissolution of retained ductal gallstones with monooctanoin in t tube patients. American Surgeon 58(2): 141-145, 1992

In vitro dissolution of gallstones: comparison of monooctanoin, sodium dehydrocholate, heparin, and saline. Ajr. American Journal of Roentgenology 138(2): 271-273, 1982

Dissolution of cholesterol and cholesterol calcium gallstones with mtbe and monooctanoin. Radiology 174(3 PART 2): 1079, 1990

Dissolution of cholesterol gallstones in vitro. Gallstone matrix content and diameter, not cholesterol content, predict gallstone dissolution in monooctanoin. Gastroenterology 93(1): 98-105, 1987

Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence. Medicine 61(2): 86-97, 1982

Monooctanoin for gallstones. Medical Letter on Drugs and Therapeutics 29(740): 52-52, 1987

Clinical results on monooctanoin treatment for gallstones. American Journal of Gastroenterology 83(9): 1068, 1988

Use of monooctanoin to dissolve gallstones (experimental study). Khirurgiia: 112-116, 1987

Monooctanoin use for gallstone dissolution. Drug Intelligence & Clinical Pharmacy 19(10): 708-713, 1985

Dissolution of cholesterol gallstones cgs with methyl tert butyl ether mtbe using an infusion aspiration pump phase i clinical studies. Gastroenterology 100(5 PART 2): A334, 1991

Dissolution rate of cholesterol in monooctanoin. Hepatology 4(5 Suppl): 166s-168s, 1984

Dissolution of biliary calculi with monooctanoin. Vestnik Khirurgii Imeni I. I. Grekova 138(5): 135-140, 1987